The health threat of drugs of abuse adulteration by new psychoactive substances

被引：4
|
作者：
Minutillo, A. [1 ]
Palmi, I. [1 ]
Mastrobattista, L. [1 ]
机构：
[1] Ist Super Sanita, Ctr Nazl Dipendenze & Doping, Viale Regina Elena 299, I-00161 Rome, Italy
来源：
CLINICA TERAPEUTICA | 2019年 / 170卷 / 06期
关键词：
new psychoactive substances; adulteration; drug of abuse; HEROIN; GHB;
D O I：
10.7417/CT.2019.2170
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The practice of drug of abuse adulteration is changing. Currently, the risk of new adulteration practices involves New Psychoactive Substances (NPS), which can also be used as adulterants. In particular, the phenomenon of adulteration concerns fentanyl and its analogs, substances that can be toxic even if taken in very small quantities. The adulteration that involves NPS is creating a serious threat to the health of drug users, not only because of the pharmacological action but because of the increased toxicity of these new cutting agents.
引用
收藏
页码：E425 / E426
页数：2
相关论文
共 50 条
  • [31] Simultaneous determination of 137 drugs of abuse, new psychoactive substances, and novel synthetic opioids in meconium by UHPLC-QTOF
    Ángela López-Rabuñal
    Daniele Di Corcia
    Eleonora Amante
    Marta Massano
    Angelines Cruz-Landeira
    Ana de-Castro-Ríos
    Alberto Salomone
    Analytical and Bioanalytical Chemistry, 2021, 413 : 5493 - 5507
  • [32] Simultaneous determination of 137 drugs of abuse, new psychoactive substances, and novel synthetic opioids in meconium by UHPLC-QTOF
    Lopez-Rabunal, Angela
    Di Corcia, Daniele
    Amante, Eleonora
    Massano, Marta
    Cruz-Landeira, Angelines
    De-Castro-Rios, Ana
    Salomone, Alberto
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2021, 413 (21) : 5493 - 5507
  • [33] New psychoactive substances
    Krabseth, Hege M.
    Tuv, Silja S.
    Strand, Maren Cecilie
    Karinen, Ritva A.
    Wiik, Elisabeth
    Vevelstad, Merete S.
    Westin, Andreas Austgulen
    Oiestad, Elisabeth L.
    Vindenes, Vigdis
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (08) : 714 - 717
  • [34] ABUSE AND DEPENDENCE TO PSYCHOACTIVE-DRUGS
    DELAFUENTE, R
    MEDINAMORA, E
    SALUD MENTAL, 1987, 10 (02) : 14 - 21
  • [35] New psychoactive substances
    Davidson, Colin
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 39 (02): : 219 - 220
  • [36] ABUSE OF PSYCHOACTIVE SUBSTANCES - TODAYS SCENE IN SLOVENIA
    TOMORI, M
    ZDRAVSTVENI VESTNIK, 1992, 61 (03): : 123 - 125
  • [37] New psychoactive substances: Are there any good options for regulating new psychoactive substances?
    Reuter, Peter
    Pardo, Bryce
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 40 : 117 - 122
  • [38] New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
    Vidal Gine, Claudio
    Fornis Espinosa, Ivan
    Ventura Vilamala, Mireia
    DRUG TESTING AND ANALYSIS, 2014, 6 (7-8) : 819 - 824
  • [39] Fentanyl and its derivatives as a group of new psychoactive substances (designer drugs)
    Zawadzki, Marcin
    Nowak, Karolina
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2018, 72 : 547 - 556
  • [40] Addressing the public health impact of new psychoactive substances: early analysis of the effects of the UK's Psychoactive Substances Act on poisons centre enquiries related to drugs of misuse
    Al Banaa, Israa
    Hawkins, Leonard C.
    Lupton, David J.
    Jackson, Gillian
    Sandilands, Euan A.
    Thompson, John P.
    Bradberry, Sally M.
    Hill, Simon L.
    Thomas, Simon H. L.
    CLINICAL TOXICOLOGY, 2017, 55 (05) : 440 - 441
12345